Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO

  • PDF / 1,213,387 Bytes
  • 12 Pages / 595.276 x 790.866 pts Page_size
  • 113 Downloads / 195 Views

DOWNLOAD

REPORT


(2020) 15:249

RESEARCH

Open Access

Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH) Kimmo Weisshaar1, Hannah Ewald2,3, Jörg Halter1, Sabine Gerull1, Sandra Schönfeld1, Yuliya Senft1, Maria Martinez4, Anne Leuppi-Taegtmeyer5, Nina Khanna6, Birgit Maier7, Antonio Risitano8,9, Regis Peffault de Latour9,10, Andre Tichelli1, Jakob Passweg1 and Beatrice Drexler1*

Abstract Background: The introduction of new therapy modalities has significantly improved the outcome of aplastic anemia (AA) and paroxysmal nocturnal hemoglobinuria (PNH) patients. However, relatively little is known about the exact disease burden of AA/PNH since standardized assessments of symptoms including health-related quality of life (HRQoL) are frequently missing or inadequately designed for this rare patient group. We aimed to develop AA/ PNH-specific questionnaires for self-reporting of symptoms, which could be included in electronic platforms for data collection and patient care. Methods: By scoping review, we extracted any reported symptoms in AA/PNH and their prevalence from the literature (Phase I). Consensus rounds with patients and medical experts were conducted to identify core symptoms reported in the literature and to add missing items (Phase II). Ultimately, AA/PNH-specific patient-reported outcome (PRO) questionnaires including the selected measures were designed (Phase III). Results: AA symptoms from 62 and PNH symptoms from 45 observational studies were extracted from the literature. Twenty-four patients and seven medical experts identified 11 core symptoms including HRQoL issues after three consensus rounds. Significant differences in the symptom ranking of patients versus medical experts could be observed. Therefore, patient- as well as expert-centered PRO questionnaires in AA and PNH were created following the concepts of validated instruments. Conclusion: The development of symptom self-reporting questionnaires for AA and PNH was feasible and the disease-specific PRO questionnaires can now be validated within a web-based workflow in a subsequent feasibility study. Keywords: Aplastic anemia, Paroxysmal nocturnal hemoglobinuria, Patient-reported outcome, Quality of life, Symptom

* Correspondence: [email protected] 1 Division of Hematology, University Hospital Basel, 4031 Basel, Switzerland Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article'